Fields Howard L
Department of Neurology, University of California, San Francisco, CA 94608, USA.
Reg Anesth Pain Med. 2007 May-Jun;32(3):242-6. doi: 10.1016/j.rapm.2007.01.001.
Opioids acting at the mu opioid (MOP) receptor produce powerful analgesia. They also produce an intensely rewarding effect that can lead to addiction. The analgesic effect of MOP receptor agonists derives from a direct inhibitory effect on pain transmission at the spinal-cord level and through activation of a descending pain-modulatory pathway. The rewarding effect of MOP agonists is the result of their actions in the mesostriatal dopamine pathway classically associated with both natural and drug rewards. Both the analgesic and rewarding effect of MOP agonists are best understood in the context of decision making under conditions of conflict. Pain is one of many competing motivational states, and endogenous opioids suppress responses to noxious stimuli in the presence of conflicting motivations, such as hunger or a threatening predator. When a food reward is available, MOP agonists microinjected into the mesostriatal circuit promote its consumption, while concomitantly suppressing responses to noxious stimulation. The mesostriatal "reward" circuit, thus, appears to perform a function critical to decision making and can either amplify or suppress responses to noxious stimuli.
作用于μ阿片受体(MOP)的阿片类药物可产生强效镇痛作用。它们还会产生强烈的奖赏效应,可能导致成瘾。MOP受体激动剂的镇痛作用源于对脊髓水平疼痛传递的直接抑制作用,以及通过激活下行疼痛调节通路。MOP激动剂的奖赏效应是其在中脑纹状体多巴胺通路中发挥作用的结果,该通路经典地与自然奖赏和药物奖赏相关。MOP激动剂的镇痛和奖赏效应在冲突条件下的决策背景中最易理解。疼痛是众多相互竞争的动机状态之一,内源性阿片类物质在存在冲突动机(如饥饿或威胁性捕食者)的情况下会抑制对有害刺激的反应。当有食物奖赏时,微量注射到中脑纹状体回路中的MOP激动剂会促进其摄取,同时抑制对有害刺激的反应。因此,中脑纹状体“奖赏”回路似乎对决策起着关键作用,并且可以放大或抑制对有害刺激的反应。